Clinical Trials Logo

Filter by:
NCT ID: NCT02150876 Completed - Clinical trials for Coronary Artery Disease

SWiss Evaluation of Bioabsorbable Polymer-coated Everolimus-eluting Coronary sTent

Start date: June 2014
Phase: N/A
Study type: Observational

Bioresorbable polymer drug eluting stents (DES) are an indisputable improvement over first-generation DES with promising results on long-term adverse events. But the thicker polymer and/or strut may hinder its deliverability. Complex procedures challenge stent deliverability and stent delivery failure impacts clinical prognosis. This registry aimed to assess the immediate performance of the third-generation Synergy everolimus-eluting stent (sEES) and its 12-month clinical follow-up in an all-comer population.

NCT ID: NCT02150642 Completed - Clinical trials for Neurological Movement Disorders

Probing Neural Circuitry for the Control of Movement

Start date: May 2004
Phase:
Study type: Observational

The investigators are interested in examining 1) the basic organization of spinal and cortical circuitry for the control of movement and 2) the influence of injury of these circuits. To investigate the neuronal circuitry, the investigators use various types of mechanical or electrical stimulation of the limbs, transcranial magnetic stimulation of the cortex and galvanic vestibular stimulation in both uninjured human subjects and subjects with a neurological injury (such as spinal cord injury, or Parkinsons's disease).

NCT ID: NCT02150629 Completed - Spinal Cord Injury Clinical Trials

Investigating Kinematic and Electromyographic Changes After SCI and Their Relation to Clinical and Functional Outcome

Start date: January 2011
Phase:
Study type: Observational

The study aims at discerning specific gait patterns and elucidating locomotor control of spinal cord injured patients in order to find sensitive kinematic and electromyographic outcome measures that are able to reveal information on underlying mechanisms of normal and aberrant gait control and its recovery over time. These measures may also be used to compare the outcome across different neurological disorders.

NCT ID: NCT02150616 Active, not recruiting - Clinical trials for Interstitial Lung Disease

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep

Start date: May 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effect of travelling to moderate altitude and of nocturnal oxygen therapy during a stay at moderate altitude on breathing and sleep of patients with pulmonary hypertension or with interstitial lung disease.

NCT ID: NCT02150603 Completed - Clinical trials for Heart Defects, Congenital

Patient-Reported Outcomes in Adults With Congenital Heart Disease

APPROACH-IS
Start date: April 2013
Phase: N/A
Study type: Observational

The purpose of this study is to examine the differences in perceived health, psychosocial functioning, behavioral outcomes and quality of life of adults with congenital heart disease who are living in different areas of the world, and how these differences can be understood (e.g., differences in sense of coherence or illness perceptions).

NCT ID: NCT02150590 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep

Start date: June 1, 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effect of nocturnal oxygen therapy during a stay at moderate altitude on breathing and sleep of patients with chronic obstructive lung disease.

NCT ID: NCT02149615 Recruiting - Optic Disc Swelling Clinical Trials

Antiacne Medications Pseudotumor Cerebri

AAMPTC
Start date: April 2014
Phase: Phase 4
Study type: Interventional

The exact incidence of optic disc swelling and idiopathic intracranial hypertension in patients using antiacne medication is not known so far. The investigators hypothesize that swelling of retinal nerve fibre layer measured by optical coherence tomography is more frequent then assumed so far.

NCT ID: NCT02149511 Completed - Spinal Cord Injury Clinical Trials

Longitudinal Morphometric Changes Following SCI

Start date: September 2010
Phase:
Study type: Observational

In patients with chronic spinal cord injury, imaging of the spinal cord and brain above the level of the lesion provides evidence of neural degeneration; however, the spatial and temporal patterns of progression and their relation to clinical outcomes are uncertain. New interventions targeting acute spinal cord injury have entered clinical trials but neuroimaging outcomes as responsive markers of treatment have yet to be established. We aim to use MRI to assess neuronal degeneration above and below the level of the lesion after acute spinal cord injury. In our prospective longitudinal study, we enroll patients with acute traumatic spinal cord injury and healthy controls. We assess patients clinically and by MRI at baseline, 2 months, 6 months, 12 months, and if possible 24 months and 60 months follow-up, and controls by MRI at the same timepoints. We assess cervical atrophy in white and gray matter and use cross-sectional spinal cord area measurements to assess atrophy at cervical level (C2/C3) and in the lumbar enlargement. We use myelinsensitive magnetisation transfer (MT) and longitudinal relaxation rate (R1) maps in the brain to assess microstructural changes associated with myelin. We also use diffusion tensor imaging acquired in the spinal cord at C2/C3 and in the lumbar enlargement to identify axonal loss and demyelination in the spinal white matter. Finally, we assess associations between MRI parameters and clinical improvement.

NCT ID: NCT02149355 Recruiting - Clinical trials for Fourth Cranial Nerve Palsy

Teeth and Jaw Misalignment in Patients Suffering From Congenital Fourth Cranial Nerve Palsy

IVPareseZahn
Start date: March 2014
Phase: N/A
Study type: Observational

Patients suffering from congenital fourth cranial nerve palsy may have misalignment of jaws as well as teeth due to head tilt in childhood.

NCT ID: NCT02149225 Completed - Glioblastoma Clinical Trials

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Start date: October 2014
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to assess the safety and tolerability, feasibility and biological activity (immunogenicity) of the actively personalized vaccination (APVAC) concept in newly diagnosed glioblastoma (GB) patients.